Clinical Trial Update: Alzheimer's Disease: Potential Benefit of Isoflavones [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating potential benefit of isoflavones in Alzheimer's disease completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Isoflavones (isoflavones)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-01-22